SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, IndiaSarah Cherian, NIC Team, Varsha Potdar et al.|Microorganisms|2021Cited by 658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddhartha Dutta, Vamshi Sarangi et al.|The Lancet|2021Cited by 361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, IndiaSarah Cherian, Varsha Potdar, Santosh Jadhav et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 268
First isolation of SARS-CoV-2 from clinical samples in IndiaPrasad Sarkale, Priya Abraham, Savita Patil et al.|The Indian Journal of Medical Research|2020Cited by 120
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trialRaches Ella, Siddarth Reddy, William C. Blackwelder et al.|medRxiv|2021Cited by 80